+Vote!
Market Wire (Free subscription) | 23/09/2008
SAN FRANCISCO, CA (MARKET WIRE) Barclays Global Investors (BGI), one of the world's largest institutional asset managers and Exchange Traded Funds (ETF) managers, announced today the successful transfer of the iShares Nasdaq Biotechnology Index Fund (ticker: IBB) from the American Stock Exchange to The NASDAQ Stock Market and the iShares S&P 100 Index Fund (ticker: OEF) from the Chicago Board Options...
+Vote!
Mondo Visione (Free subscription) | 23/09/2008
The NASDAQ OMX Group, Inc. (Nasdaq: NDAQ ) today announced that the iShares(r) Nasdaq Biotechnology Index Fund (Nasdaq: IBB ) began trading today on The NASDAQ Stock Market(r) (NASDAQ(r)). Barclays Global Investors (BGI), one of the world's largest institutional asset managers and Exchange Traded Funds (ETF) managers, transferred the fund to NASDAQ from the American Stock Exchange.
- send to a friend
-
Explore : Biotechnology, Financial Services, IShares, Markets, Money, NASDAQ, NASDAQ Stock Market Inc, Nonequity Investment Instruments, Stock exchange, Stock markets, Stocks
+Vote!
Market Wire (Free subscription) | 02/09/2008
SAN FRANCISCO, CA (MARKET WIRE) Barclays Global Investors (BGI), one of the world's largest institutional asset managers and Exchange Traded Funds (ETF) managers, today announced the transfer of the iShares Nasdaq Biotechnology Index Fund (ticker: IBB) from the American Stock Exchange to The NASDAQ Stock Market and the move of the iShares S&P 100 Index Fund (ticker: OEF) from the Chicago Board Options...
+Vote!
PR News Wire (Free subscription) | 13/05/2008
DANBURY, Conn., May 13 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq:
BIOD) today announced that the Company has been selected for inclusion in
the NASDAQ Biotechnology Index (NBI), effective as of the market's open on
Monday, May 19, 2008.
"We are pleased to be included in the NASDAQ Biotechnology Index and
believe Biodel's inclusion is a result of the Company's consistent
achievement of its goals,"...
+Vote!
Business Wire (Free subscription) | 12/05/2008
LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), today announced that the Company has been selected for inclusion in the NASDAQ Biotechnology Index (NBI),
1Vote!
Mondo Visione (Free subscription) | 10/05/2008
The NASDAQ OMX Group, Inc. ("NASDAQ") (Nasdaq: NDAQ ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index(r) (Nasdaq: NBI ), which will become effective with the market open on Monday, May 19, 2008.
+Vote!
BioHealth Investor (Free subscription) | 19/03/2008
by H.S. Ayoub, DMD BioHealth Investor Nasdaq Biotechnology Index (^NBI) -2.92% Amex Pharmaceutical Index (^DRG) -2.69% iShares Dow Jones Medical Devices (IHI) -1.25% Kosan Biosciences (KOSN) up 24.34%... investors were cheering the company's... (click article title to read more...)
+Vote!
BioHealth Investor (Free subscription) | 18/03/2008
by H.S. Ayoub, DMD BioHealth Investor Nasdaq Biotechnology Index (^NBI) +2.85% Amex Pharmaceutical Index (^DRG) +2.30% iShares Dow Jones Medical Devices (IHI) +3.03% Ista Therapeutics (ISTA) up 39.10%... Well, I guess the company's... (click article title to read more...)
